Purpose: The aim of this study was to evaluate the severity of menopausal symptoms and their impact on the quality of life (QOL) in breast cancer patients with chemotherapy-induced amenorrhea.Methods: A cross-sectional survey design was used.Participants were 112 breast cancer patients with chemotherapy-induced amenorrhea.They completed the Menopause Rating Scale (MRS) and the Functional Assessment of Cancer Therapy-General (FACT-G).Data were analyzed using descriptive statistics, independent ttests, one-way ANOVA, Pearson' s correlation coefficients, and multiple regression with SPSS/WIN 23.0.Results: The prevalence of symptoms among the participants were as follows: sleep problems, 88.4%; physical and mental exhaustion, 80.4%; joint and muscular discomfort, 76.8%; and depression, 70.5%.Menopausal symptoms had a significant negative association with QOL.The results of the regression analysis showed that psychological and urogenital symptoms were statistically significant in explaining patients' QOL and accounted for 70% of the total variance.Conclusion: Menopausal symptoms appear to be a significant problem for premenopausal breast cancer patients.Assessment and control of menopausal symptoms played a large role in maintaining the quality of life in breast cancer patients.
No takes yet. Share an insight, caveat, or question.
Park et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: